The nice
people at Transfusion News sent their update today. I like Transfusion News.
Unlike other sources of CPD who bombard me with information (until my head
is for to burst), the nice people at Transfusion News have three articles.
A manageable amount…
Screening for SARS-CoV-2 RNA in U.S. Blood Donors
 | | June 8, 2021 | | In
March 2020, just a few months after the COVID-19 pandemic began in
China, the U.S. launched the REDS Epidemiology, Surveillance and
Preparedness of Novel SARS-CoV-2 (RESPONSE) study to determine the
safety of the blood supply—specifically seroprevalence in blood donors
and transfusion-transmission of SARS-CoV-2. [Read More] |
|
 | | In
this webinar, Sofia Lejon Crottet, PhD, head of the Swiss National
Immunohematology Reference Laboratory, will explain how a reference
laboratory deals with anti-CD38, the various methods available, their
pros and cons, as well as their financial impacts. In this review, Sofia
will share with us case studies that demonstrate how pretransfusion
testing can be efficiently completed. She will give an overview on
factors to be considered when choosing a method for eliminating
Daratumumab interference. [Register Now] |
|
 | |
| June 2, 2021 | | Since
hemoglobin thresholds for anemia are currently based on data collected
over 50 years ago in Caucasian adults, the WHO is calling for a
re-examination of these thresholds. One suggested approach is to define
anemia by age- and sex-appropriate hemoglobin cut-offs—namely the lowest
5% in an otherwise healthy population. These data, however, are scarce
in low- and middle-income countries.[Register Now] |
|
No comments:
Post a Comment